Advertisement

Moderate supplementation with natural α-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation

      Abstract

      Previous studies have shown that oral administration of 300 mg α-tocopherol/day to healthy volunteers decreases platelet function and enhances their sensitivity to the platelet inhibitor, prostaglandin E1, when full dose-response curves to a range of agonist concentrations are made. In this study, the effects of oral doses of natural α-tocopherol (75, 200 and 400 IU/day) were studied in order to determine whether the same effects might be achieved with lower intakes of vitamin E and whether inhibition is related to the platelet levels of the antioxidant in platelet membranes. Twenty two subjects undertook the supplementation regime, divided into three units of 2 weeks, each cycling through each of the dosages. The results show that uptake of vitamin E by the platelets was optimal at 75 IU/day, correlating with the maximal influence on platelet aggregation and platelet responsiveness to inhibition by PGE1, increased supplemental levels exerting no greater effects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Trip D.M.
        • Cats M.V.
        • van Capelle L.J.F.
        • Vreeken J.
        Platelet hyperreactivity and prognosis in survivors of myocardial infarction.
        N. Engl. J. Med. 1990; 22: 1549-1554
        • Elwood P.C.
        • Renaud S.
        • Sharp D.S.
        • Beswick A.D.
        • O’Brien J.R.
        • Yarnell J.W.G.
        Ischemic heart disease and platelet aggregation. The Caerphilly collaborative heart disease study.
        Circulation. 1991; 83: 39-40
        • Steinberg D.
        • Parthasarthy S.
        • Carew T.
        • Khoo J.C.
        • Wiztum J.L.
        Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity.
        N. Engl. J. Med. 1989; 320: 915
        • Regnstrom J.
        • Nilsson J.
        • Tornvall P.
        • Landau C.
        • Hamsten A.
        Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man.
        Lancet. 1992; 339: 1183-1186
        • Jacobs M.
        • Plane F.
        • Bruckdorfer K.R.
        Native and oxidised LDL have differential inhibitory effects on endothelium-derived relaxing factor in rabbit aorta.
        B. J. Pharmacol. 1990; 100: 21-26
        • Stoll L.L.
        • Osjarsson H.J.
        • Spector A.A.
        Interaction of lysophosphatidylcholine with aortic endothelial cells.
        Am. J. Physiol. 1992; 262: H1853-H1860
        • Bruckdorfer K.R.
        The effects of plasma lipoproteins on platelet responsiveness and on platelet and vascular prostanoid synthesis.
        Prostagland Leukotr. Ess. Fatty Acids. 1989; 38: 247-254
        • Meraji S.
        • Moore C.E.
        • Skinner V.O.
        • Bruckdorfer K.R.
        The importance of oxidation and glycosylation of low density lipoproteins on platelet function.
        Platelets. 1992; 3: 155-162
        • Weidtmann A.
        • Scheithe R.
        • Hrboticky N.
        • Pietsch A.
        • Lorenz R.
        • Siess W.
        Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2.
        Arterioscler. Thromb. Vasc. Biol. 1995; 15: 1131-1138
        • Naseem K.M.
        • Goodhall A.H.
        • Bruckdorfer K.R.
        Differential effects of native oxidatively modified lipoproteins on platelet function.
        Platelets. 1997; 8: 163-173
        • Kulmacz R.J.
        • Lands W.E.M.
        Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase.
        Prostaglandins. 1983; 25: 531-540
        • Rice-Evans C.A.
        • Bruckdorfer K.R.
        Free radicals, lipoproteins and cardiovascular dysfunction.
        Mol. Aspect. Med. 1992; 13: 1-111
        • Kok F.J.
        • de Bruijn A.M.
        • Vermeeren R.
        Serum selenium, vitamin antioxidants and cardiovascular mortality: a year follow-up study in the Netherlands.
        Am. J. Clin. Nutr. 1987; 45: 462-468
        • Hense H.W.
        • Stender M.
        • Bors W.
        • Keil U.
        Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels.
        Atherosclerosis. 1993; 103: 28
        • Rimm E.B.
        • Stampfer M.J.
        • Ascherio A.
        • Giovannucci E.
        • Coldicz G.A.
        • Willett W.C.
        Vitamin E consumption and the risk of coronary disease in woman.
        N. Engl. J. Med. 1993; 328: 1450-1456
        • Stampfer M.J.
        • Henneckens C.H.
        • Manson J.E.
        • Colditz G.A.
        • Rosner B.
        • Willett W.C.
        Vitamin E consumption and the risk of coronary disease in women.
        N. Engl. J. Med. 1993; 328: 1444-1449
        • Diplock A.T.
        Antioxidants and disease prevention.
        Mol. Aspects Med. 1994; 15: 293-376
        • Odeh R.M.
        • Cornish L.A.
        Natural antioxidants for the prevention of atherosclerosis.
        Pharmacotherapy. 1995; 15: 648-659
        • Stephens N.G.
        • Parsons A.
        • Schonfield P.M.
        • Kelly F.
        • Cheeseman K.
        • Mitchinson M.J.
        Randomised controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant (CHAOS).
        Lancet. 1996; 347: 718-786
        • Esterbauer H.
        • Gebicki J.
        • Puhl H.
        • Jurgens G.
        The role of lipid peroxidation and antioxidants in oxidative modification of LDL.
        Free Rad. Biol. Med. 1992; 13: 341-390
        • Princen H.M.G.
        • van Duyvenvoorde W.
        • Buytenhek R.
        • van der Laarse A.
        • van Poppel G.
        • Gevers Leuven J.A.
        • van Hinsbergh V.W.M.
        Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women.
        Arterioscler. Thromb. Vasc. Biol. 1995; 15: 325-333
      1. Jialal I, Fuller CJ. Effect of vitamin E, vitamin C and β-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl 97S–103S.

        • Reaven P.
        • Khouw A.
        • Betz W.
        • Parthasarathy S.
        • Witztum J.L.
        Effect of dietary antioxidant combinations in humans: protection of low density lipoproteins by vitamin E but not by β-carotene.
        Arterioscler. Thromb. 1993; 13: 590-600
        • Steiner M.
        Vitamin E changes membrane fluidity of human platelets.
        Biochim. Biophys. Acta. 1981; 640: 100-105
        • Steiner M.
        • Anastasi J.
        Vitamin E, an inhibitor of the platelet release reaction.
        J. Clin. Invest. 1976; 57: 732-737
        • Fong J.S.C.
        Alpha-tocopherol: its inhibition on human platelet aggregation.
        Experientia. 1976; 32: 639-641
        • White J.G.
        • Rao G.H.R
        • Gerrard J.M.
        Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation and secretion.
        Am. J. Pathol. 1977; 88: 387-401
        • Steiner M.
        Effect of alpha-tocopherol administration on platelet function in man.
        Thromb. Haemost. 1983; 49: 73-77
        • Richardson P.D.
        • Mohammed S.F.
        • Mason R.G.
        Flow chamber studies of platelet adhesion at controlled spatially varied shear rates.
        Proc. Eur. Soc. Artif. Organs. 1977; 4: 175-188
        • Stampfer M.J.
        • Jakubowski J.A.
        • Faigel D.
        • Vaillancourt R.
        • Deykin D.
        Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism and plasma prostacyclin levels.
        Am. J. Clin. Nutr. 1988; 47: 700-706
        • Kockmann V.
        • Véricel E.
        • Croset M.
        • Largarde M.
        Vitamin E fails to alter the aggregation and the oxygenated metabolism of arachidonic acid in normal human platelets.
        Prostaglandins. 1988; 36: 607-620
        • Salonen J.Y.
        • Salonen R.
        • Seppanen K.
        • Rinta-Kiikka S.
        • Kuukka M.
        • Korpela H.
        • Alfthan G.
        • Kantola M.
        • Schalch W.
        Effects of antioxidant supplementation on platelet function; a randomised pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status.
        Am. J. Clin. Nutr. 1991; 53: 1222-1229
        • Calazada C.
        • Bruckdorfer K.R.
        • Rice-Evans C.A.
        The influence of antioxidant nutrients on platelet function in healthy volunteers.
        Atherosclerosis. 1997; 128: 97-105
        • Lagarde M.
        • Burtin M.
        • Berciaud P.
        • Blanc M.
        • Velardo B.
        • Dechanave M.
        Increase of platelet thromboxane A2 formation and its plasmatic half-life in diabetes mellitus.
        Thromb. Res. 1980; 19: 823-830
      2. Warnick GR. Enzymatic methods for quantification of lipoproteins lipids, In: Colowick N, Kaplan O, editors. Methods in Enyzmol. London: Academic Press, 1986;129:101–123.

        • Assman G.
        • Schriewer H.
        • Schmitz G.
        • Hagel E.O.
        Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.
        Clin. Chem. 1983; 29: 2026-2030
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499-502
      3. Rice-Evans CA, Diplock AT, Symons MRC. In: Techniques in Free Radical Research. Amsterdam: Elsevier, 1991.

        • Chung B.H.
        • Wilkinson T.
        • Geer J.C.
        • Segrest J.C.
        Preparative and quantitative isolation of plasma lipoprotein s: rapid single discontinuous density gradient ultracentrifugation in the vertical rotor.
        J. Lipid Res. 1980; 221: 284-317
        • Markwell M.A.
        • Hass S.M.
        • Bieber L.L.
        • Tolbert N.E.
        A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein.
        Anal. Biochem. 1978; 87: 206-210
        • Esterbauer H.
        • Striegl G.
        • Puhl H.
        • Rotheneder M.
        Continuous monitoring of in vitro oxidation of human low density lipoproteins.
        Free Rad. Res. Comm. 1989; 6: 67-75
        • Born G.V.R.
        Aggregation of blood platelets by adenosine diphosphate and its reversal.
        Nature. 1962; 194: 927
        • Gey K.F.
        • Moser U.K.
        • Jordan P.
        • Stahelin H.B.
        • Eichholzer M.
        • Luedin E.
        Increased risk of cardiovascular disease at sub-optimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C.
        Am. J. Clin. Nutr. 1993; 57: 787S-797S
        • Riemersma R.A.
        • Wood D.A.
        • Macintyre C.C.A.
        • Elton R.A.
        • Gey K.F.
        • Oliver M.F.
        Risk of angina pectoris and plasma concentrations of vitamins A, C and E, and carotene.
        Lancet. 1991; 337: 1-5
        • Jessup W.
        • Rankin S.M.
        • De Whalley C.V.
        • Hoult J.R.S.
        • Scott J.
        • Leake D.S.
        Tocopherol consumption during low-density lipoprotein oxidation.
        Biochem. J. 1990; 265: 399-405
        • Dieber-Rotheneder M.
        • Puhl H.
        • Waeg G.
        • Striegel G.
        • Esterbauer H.
        Effect of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoproteins and its oxidative resistance.
        J. Lipid Res. 1991; 32: 1325-1332
        • Jialal I.
        • Grundy S.M.
        Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoproteins.
        J. Lipid Res. 1992; 33: 899-906
        • Calzada C.
        • Bizzotto M.
        • Paganga G.
        • Miller N.J.
        • Bruckdorfer K.J.
        • Diplock A.T.
        • Rice-Evans C.A.
        Levels of antioxidant nutrients in plasma and low density lipoproteins: a human volunteer supplementation study.
        Free Rad. Res. 1995; 23: 489-503
        • Stibert P.L.
        • Leong L.L.
        • Sturm M.J.
        • Stropham J.
        • Taylor R.R.
        Short term vitamin E supplementation has no effect on platelet function, plasma phospholipase A2 and lyso-PAF in male volunteers.
        Clin. Exp. Pharmacol. Physiol. 1990; 17: 645-651
        • Abbey M.
        • Nestel P.J.
        • Baghurst P.A.
        Antioxidant vitamins and low-density lipoprotein oxidation.
        Am. J. Clin. Nutr. 1993; 58: 525-532
        • Vatassery G.T.
        • Krezowski A.M.
        • Eckfeld J.H.
        Vitamin E concentration in human blood plasma and platelets.
        Am. J. Clin. Nutr. 1983; 37: 1020-1024
        • Lehmann J.
        • Rao D.D.
        • Canary J.J.
        • Judd J.T.
        Vitamin E and relationships among tocopherols in human plasma, platelets, lymphocytes and red blood cells.
        Am. J. Clin. Nutr. 1988; 47: 470
        • Weiss S.J.
        • Turk J.
        • Needleman P.A.
        Mechanism for the hydroperoxide-mediated inactivation of prostacyclin synthetase.
        Blood. 1979; 53: 916
        • Freedman J.E.
        • Farhat J.H.
        • Loscalzo J.
        • Keaney J.F.
        Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase c-dependent mechanism.
        Circulation. 1996; 94: 2434-2440
        • Sevitt S.
        Platelets and foam cells in the evolution of atherosclerosis. Histological and immunological studies of human lesions.
        Atherosclerosis. 1986; 61: 107-110
        • Aviram M.
        LDL–platelet interaction under oxidative stress induces macrophage foam cell formation.
        Thromb. Haemostas. 1995; 74: 560-564
        • Ardlie N.G.
        • Selley M.L.
        • Simons L.A.
        Platelet activation by oxidatively modified low density lipoproteins.
        Atherosclerosis. 1989; 76: 117-124
        • Rijike Y.B.
        • Vogelgzang C.J.M.
        • Van Berkel T.J.C.
        • Princen H.M.G.
        • Verwey H.F.
        • Van der Laarse A.
        • Bruschke A.V.G.
        Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients.
        Lancet. 1992; 340: 858-859
        • Cominacini L.
        • Garbini U.
        • Pastorino A.M.
        • et al.
        Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.
        Atherosclerosis. 1993; 99: 63-70
        • van de Vijver L.P.
        • Kardinaal A.F.
        • van Duyvenvoorde W.
        • Kruijssen D.A.
        • Grobbee D.E.
        • van Poppel G.
        • Princen H.M.
        LDL oxidation and extent of coronary atherosclerosis.
        Arterioscler. Thromb. Vasc. Biol. 1998; 18: 193-199
        • Rapola J.M.
        • Virtamo J.
        • Ripatti S.
        • Huttunen J.K.
        • Albanes D.
        • Taylor P.R.
        • Heinonen O.P.
        Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
        Lancet. 1997; 349: 1715-1720
        • Virtamo J.
        • Rapola J.M.
        • Ripatti S.
        • Heinonen O.P.
        • Taylor P.R.
        • Albanes D.
        • Huttunen J.K.
        Effect of vitamin E and beta-carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.
        Arch. Int. Med. 1998; 158: 668-675